Investigating the continuous synthesis of a nicotinonitrile precursor to nevirapine

    • Ashley R. Longstreet1
    • Suzanne M. Opalka1
    • Brian S. Campbell1
    • B. Frank Gupton2
    • Tyler McQuade1
    • 1 Department of Chemistry and Biochemistry, Florida State University, United States
    • 1 Department of Chemistry, Virginia Commonwealth University, United States

    2-Chloro-3-amino-4-picoline (CAPIC) is a strategic building block for the preparation of nevirapine, a widely-prescribed non-nucleosidic reverse transcriptase inhibitor for the treatment of HIV-infected patients. A continuous synthesis to the bromo derivative of a CAPIC intermediate, 2-bromo-4-methylnicotinonitrile, that terminates in a dead-end crystallization is described. The route uses inexpensive, acyclic commodity-based raw materials and has the potential to enable lower cost production of nevirapine as well as other value added structures that contain complex pyridines. The route terminates in a batch crystallization yielding high purity CAPIC. This outcome is expected to facilitate regulatory implementation of the overall process.

    Read the publication that featured this abstract

    Get in touch

    For more information on flow chemistry systems and services please use the contact methods below.

    Call us on +44 (0)1284 728659 or Email us